Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

AM Best Affirms Credit Ratings of The Allstate Corporation and Its Key Subsidiaries

Published

on

Reading Time: 4 minutes

OLDWICK, N.J.–(BUSINESS WIRE)–AM Best affirmed the Financial Strength Rating (FSR) of A+
(Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of
“aa” of the members of Allstate Insurance Group (Allstate).
Additionally, AM Best has affirmed the FSR of A (Excellent) and the
Long-Term ICRs of “a” of the members of Allstate New Jersey Insurance
Group (collectively referred to as Allstate New Jersey) (headquartered
in Bridgewater, NJ). Concurrently, AM Best has affirmed the FSR of A+
(Superior) and the Long-Term ICRs of “aa” of the key life/health members
of the Allstate Life Group (Allstate Life). At the same time, AM Best
has affirmed the Long-Term ICR of “a”, and all existing Long- and
Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of the
ultimate parent, The Allstate Corporation (Allcorp). The outlook of
these Credit Ratings (ratings) is stable.

All the above named companies are headquartered in Northbrook, IL,
except where specified. (See link below for a detailed listing of the
companies and ratings.)

The ratings of Allstate reflect its balance sheet strength, which AM
Best categorizes as strongest, as well as its strong operating
performance, favorable business profile and very strong enterprise risk
management (ERM).

Allstate’s strong capital position reflects its favorable earnings,
which have contributed to organic surplus growth in each of the past
five years on a pre-dividend basis. Allstate’s operating results
continue to be favorable due to enhanced pricing sophistication, and
improved loss cost and expense management while maintaining underwriting
discipline. Additionally, Allstate has a significant market presence and
favorable overall business profile as one of the largest personal lines
writers in the United States. Allstate also benefits from the additional
liquidity provided by Allcorp and its subsidiary, Kennett Capital, Inc.,
and through access to capital markets, lines of credit and its
commercial paper program. The group’s favorable margins are attributable
to enhanced pricing accuracy and risk optimization, along with its solid
core underwriting capabilities, prudent capital management and sizable
investment income. Lastly, underwriting results also reflect the
favorable impact of Allstate’s ongoing risk management actions, various
expense management initiatives and its significant investment in
technology, as Allstate has shown the ability to adapt quickly to market
trends to ensure continued underwriting and operating profitability.

Partially offsetting these positive rating attributes is Allstate’s
inherent exposure to natural disasters due to its expansive market
presence throughout the United States. However, Allstate over the past
several years has maintained an extensive catastrophe risk exposure
management program, including a significantly enhanced property
catastrophe reinsurance program, stricter underwriting guidelines,
increased deductibles and discontinuance of selected lines of coverage
such as earthquake. In addition, this expansive geographic presence
provides inherent diversification against the impact of one or a few
significant weather events. The group’s underwriting results in recent
years have benefited from these risk-management actions. While the group
maintains above-average underwriting and investment leverage, relative
to industry norms, it has maintained capital levels supportive of its
business risks.

The ratings of Allstate New Jersey reflect its balance sheet strength,
which AM Best categorizes as very strong, as well as its strong
operating performance, limited business profile and appropriate ERM.
Additionally, the ratings recognize the financial strength, ERM and
continued support of Allstate Insurance Company, as well as Allcorp.

Allstate New Jersey maintains favorable risk-adjusted capitalization,
consistently profitable operating performance and management’s local
market knowledge. These positive rating attributes are offset partially
by the group’s business concentration within one state, resulting in
potential operating variability due to local market disruptions and
localized catastrophe weather events. The ratings further recognize the
consistent profitability trends in underwriting in recent years, along
with the expectation that trends in capitalization and operating
performance will continue in the near to medium term.

The ratings of Allstate Life reflect its balance sheet strength, which
AM Best categorizes as very strong, as well as its strong operating
performance, favorable business profile and very strong ERM.
Additionally, the ratings recognize the financial strength and continued
support of Allstate Insurance Company, as well as Allcorp.

Allstate Life’s overall balance sheet strength assessment is supported
by its very strong risk-adjusted capitalization and favorable liquidity,
as well as the organization’s expertise in stress testing and economic
capital modeling. Partially offsetting these strengths are the company’s
somewhat higher level of investment risk as a percentage of capital and
surplus, which is also higher than industry benchmarks. This risk is
mitigated partially by the use of a barbell asset allocation strategy,
which allows for longer dated annuity liabilities to be backed by
alternative assets, and the utilization of cash flow duration-matched
assets for shorter dated liabilities.

Allstate Life’s strong operating performance benefits from its core
traditional life and voluntary benefit product sales growth and its
favorable underwriting results, which are enhanced by a consistent
stream of net investment income. The company continues to manage the
run-off of its declining, yet sizable, exposure to interest sensitive
business within its annuities segment. Allstate Life’s recognized market
presence and strength of distribution across the organization create
additional benefits and synergies that drive its ability to compete in
its core markets. The company continues to work toward further
enhancement of digital capabilities in order to create a streamlined
consumer experience and increased efficiency. Allstate Life benefits
from a very strong risk culture and governance that has been embedded
throughout the organization.

A complete
listing
of The Allstate Corporation and its property/casualty and
life/health subsidiaries’ FSRs, Long-Term ICRs and Long- and Short-Term
IRs also is available.

This press release relates to Credit Ratings that have been published
on AM Best’s website. For all rating information relating to the release
and pertinent disclosures, including details of the office responsible
for issuing each of the individual ratings referenced in this release,
please see AM Best’s
Recent
Rating Activity
web page. For additional information
regarding the use and limitations of Credit Rating opinions, please view
Understanding
Best’s Credit Ratings
. For information on the proper media
use of Best’s Credit Ratings and AM Best press releases, please view
Guide
for Media – Proper Use of Best’s Credit Ratings and AM Best Rating
Action Press Releases
.

AM Best is a global rating agency and information provider with a
unique focus on the insurance industry. Visit
www.ambest.com
for more information
.

Copyright © 2019 by A.M. Best Rating Services, Inc. and/or its
affiliates. ALL RIGHTS RESERVED.

Contacts

Edin Imsirovic
Senior Financial Analyst – P/C
+1
908 439 2200, ext. 5740

[email protected]

Christopher
Sharkey

Manager, Public Relations
+1 908 439
2200, ext. 5159

[email protected]

Kate
Steffanelli

Senior Financial Analyst- L/H
+1 908
439 2200, ext. 5063

[email protected]

Jim
Peavy

Director, Public Relations
+1 908 439
2200, ext. 5644

[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

on

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to,  the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html

Continue Reading

Cannabis

Right on Brands Announces Major Product Line Expansion via HONEY® Brands

Published

on

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania